USPTO serial 79206898
KROVOSPAS
Reviewed by CopyMark Law Group
Reg. 5440464Status 404
- Filing date
- Status date
- Registration date
- Apr 10, 2018
- Examiner
- RINKER, ANTHONY MICHAEL
- Law office
- TMO LAW OFFICE 119
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KROVOSPAS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard M. LaBarge
Richard M. LaBarge Marshall, Gerstein & Borun LLP233 S. Wacker DriveSuite 6300Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Aconitine, namely, analgesics; alginates for pharmaceutical purposes; alginate dietary supplements; aldehydes for pharmaceutical purposes; amino acids for veterinary purposes; amino acids for medical purposes; analgesics; anaesthetics; antibiotics; first-aid boxes, filled; cotton for medical purposes; aseptic cotton; bandages for dressings; cotton sticks for medical purposes; cotton swabs for medical purposes; absorbent cotton for medical purposes; gallic acid for pharmaceutical purposes; panty liners; menstruation knickers; sanitary knickers; sanitary panties; menstruation bandages; sanitary pads; sanitary napkins; sanitary towels; menstruation tampons; sanitary tampons; hydrastine, namely, hemostatics for medical purposes; hydrastinine, namely, hemostatics for medical purposes; glycerine for medical purposes; dietetic sugar adapted for medical use; esters for pharmaceutical purposes for the treatment of hemophilia, hemorrhage and bleeding control; cellulose esters for pharmaceutical purposes; ethers for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; gelatine for medical purposes; chewing gum for medical purposes; dental mastics; dental cements; hyaluronic acids for pharmaceutical purposes; bone cement for surgical and orthopaedic purposes; medicated compresses; blood for medical purposes; haemostatic pencils; hemostatic pencils; lactose for pharmaceutical purposes; milk sugar for pharmaceutical purposes; lecithin for medical purposes; lecithin dietary supplements; adhesive bands for medical purposes; adhesive tapes for medical purposes; medicine cases, portable, filled, namely, medicines for the treatment of hemophilia, hemorrhage and bleeding control; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of hemophilia, hemorrhage and bleeding control; medicines for veterinary purposes for the treatment of hemophilia, hemorrhage and bleeding control; medicines for dental purposes; medicinal roots; medicinal tea; medicinal herbs; medicinal oils; liniments; gauze for dressings; teeth filling material; menthol for pharmaceutical purposes; mineral food supplements; mint for pharmaceutical purposes; cooling sprays for medical purposes; diapers for incontinents; napkins for incontinents; peptones for pharmaceutical purposes, namely, amino acids for medical purposes; medical dressings; blood plasma; adhesive plasters for medical purposes; sticking plasters for medical use; belts for sanitary napkins; haemorrhoid preparations; sunburn preparations for pharmaceutical purposes; preparations for the treatment of burns; mouthwashes for medical purposes; preparations of trace elements for human and animal use, namely, mineral supplements; antiseptic cotton; antiseptics; radioactive substances for medical purposes; diagnostic biomarker reagents for medical purposes; radiological contrast substances for medical purposes; suppositories; tissues impregnated with pharmaceutical lotions, namely, medicated pre-moistened tissues; siccatives for medical purposes; pharmaceutical preparations for skin care; phosphates for pharmaceutical purposes for the treatment of heart disease and metabolism correction; vine disease treating chemicals; chemical preparations for veterinary purposes for the treatment of hemophilia, hemorrhage and bleeding control chemical preparations for medical purposes for the treatment hemophilia, hemorrhage and bleeding control chemical preparations for pharmaceutical purposes for the treatment of hemophilia, hemorrhage and bleeding control surgical glues; and surgical dressings | SECTION 71 - CANCELLED | — |
| 010 | Aerosol dispensers for medical purposes; bandages, elastic; cupping glasses; dental burs; vaginal syringes; plaster support bandages for orthopedic purposes; surgical sponges; drainage tubes for medical purposes; inhalers for medical purposes; catheters; catgut for surgical use; suture materials; thread, surgical; knee bandages, orthopedic; orthopedic soles; orthopaedic belts; suspensory bandages, namely, supportive bandages; hypodermic syringes; bandages for joints, anatomical; supportive bandages; and receptacles for applying medicines, namely, medical syringes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MANORYK PETRO ANDRIYOVYCH
- Other trademarks owned by MANORYK PETRO ANDRIYOVYCH
- Other trademarks owned by MANORYK PETRO ANDRIYOVYCH
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named KROVOSPAS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 5, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 18, 2025 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 1, 2025 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 1, 2025 | INPC | INVALIDATION PROCESSED | — |
| Jun 25, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 25, 2024 | C71T | CANCELLED SECTION 71 | — |
| Apr 10, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 24, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 27, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 27, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 10, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 10, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 23, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 19, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 3, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 3, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 3, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 27, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 27, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 19, 2017 | ALIE | ASSIGNED TO LIE | — |
| Nov 8, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 24, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 5, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 5, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 23, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 22, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2017 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| May 13, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 10, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 9, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 4, 2017 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |